Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)-Reference-Cited by-同舟云学术

Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)

Published:2018-03 Issue:12 Volume:97 Page:e0182
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Cao Zipei,Wei Lijuan,Zhu Weizhi,Yao Xuping

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference58 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience;Fossa;Urology,2014

3. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014

4. The genetics of castration-resistant prostate cancer: what can the germline tell us?;Sharifi;Clin Cancer Res,2008

5. Global histone post-translational modifications and cancer: biomarkers for diagnosis, prognosis and treatment?;Khan;World J Biol Chem,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a prognostic risk model for prostate cancer based on Gleason grading and cuprotosis related genes;Journal of Cancer Research and Clinical Oncology;2024-08-01

2. Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment;Human Genomics;2024-05-31

3. Epigenomics, Transcriptomics, and Translational Control in Prostate Cancer;Prostate Cancer;2024

4. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024

5. An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma;iScience;2023-10